Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Li, Ping ^a   Grgurevic, Srdana ^a   Liu, Zhiming ^a   Harris, David ^a   Rozovski, Uri ^a   Calin, George A ^a   Keating, Michael J ^a   Estrov, Zeev ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 155; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STAT3 PROTEIN;

ARTICLE; BINDING SITE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; PROMOTER REGION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

MUS;

EID: 84878653954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064678     Document Type: Article

References (34)

1. Bazargan A, Tam CS, Keating MJ, (2012) Predicting survival in chronic lymphocytic leukemia. Expert review of anticancer therapy 12: 393-403.
2. Tam CS, Keating MJ, (2010) Chemoimmunotherapy of chronic lymphocytic leukemia. Nature reviews Clinical oncology 7: 521-532.
3. Kato M, Slack FJ, (2008) microRNAs: small molecules with big roles- C. elegans to human cancer. Biology of the cell/under the auspices of the European Cell Biology Organization 100: 71-81.
4. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
5. Calin GA, (2009) MiR-sensing chemotherapy resistance in CLL. Blood 113: 3652-3653.
6. Calin GA, Croce CM, (2009) Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood 114: 4761-4770.
7. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, et al. (2008) MiR-15a and miR-16-1 cluster functions in human leukemia. Proceedings of the National Academy of Sciences of the United States of America 105: 5166-5171.
8. Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, et al. (2011) Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA: the journal of the American Medical Association 305: 59-67.
9. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England journal of medicine 353: 1793-1801.
10. Li S, Moffett HF, Lu J, Werner L, Zhang H, et al. (2011) MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PloS one 6: e16956.
11. Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ, (2011) Role of microRNA-155 in autoimmunity. Cytokine & growth factor reviews 22: 141-147.
12. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, et al. (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 103: 7024-7029.
13. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, et al. (2012) MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proceedings of the National Academy of Sciences of the United States of America 109: E2110-2116.
14. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K, (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Molecular cell 39: 493-506.
15. Hazan-Halevy I, Harris D, Liu Z, Liu J, Li P, et al. (2010) STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 115: 2852-2863.
16. Frank DA, Mahajan S, Ritz J, (1997) B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J Clin Invest 100: 3140-3148.
17. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America 102: 3627-3632.
18. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, et al. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951.
19. Vargova K, Curik N, Burda P, Basova P, Kulvait V, et al. (2011) MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia. Blood 117: 3816-3825.
20. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, et al. (2010) Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochemical and biophysical research communications 402: 390-395.
21. Li P, Harris D, Liu Z, Liu J, Keating M, et al. (2010) Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One 5: e11859.
22. Liu Z, Hazan-Halevy I, Harris DM, Li P, Ferrajoli A, et al. (2011) STAT-3 activates NF-kappaB in chronic lymphocytic leukemia cells. Mol Cancer Res 9: 507-515.
23. Aaronson DS, Horvath CM, (2002) A road map for those who don't know JAK-STAT. Science 296: 1653-1655.
24. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
25. Haasch D, Chen YW, Reilly RM, Chiou XG, Koterski S, et al. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cellular immunology 217: 78-86.
26. Leng RX, Zhu QQ, Pan HF, Feng JB, Tao JH, et al. (2011) Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison. Rheumatology international 31: 699-700.
27. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, et al. (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. The Journal of pathology 207: 243-249.
28. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A, (2004) High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes, chromosomes & cancer 39: 167-169.
29. van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, et al. (2003) High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes, chromosomes & cancer 37: 20-28.
30. Iorio MV, Croce CM, (2012) Causes and consequences of microRNA dysregulation. Cancer journal 18: 215-222.
31. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, et al. (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 94: 3801-3804.
32. Huang X, Shen Y, Liu M, Bi C, Jiang C, et al. (2012) Quantitative proteomics reveals that miR-155 Regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. The American journal of pathology 181: 26-33.
33. Wickremasinghe RG, Ganeshaguru K, Jones DT, Lindsay C, Spanswick VJ, et al. (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. British journal of haematology 114: 608-615.
34. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proceedings of the National Academy of Sciences of the United States of America 101: 11755-11760.